2 shifts in biopharma distribution via digital channels 2026
Digital channels are revolutionizing biopharma distribution in 2026, with two key shifts emerging: the rise of direct-to-provider e-platforms and the adoption of real-time cold chain monitoring. These changes are driven by biopharma companies’ need to reduce distribution costs and ensure sensitive products like monoclonal antibodies reach patients unimpaired. Direct-to-provider...
0 Commentaires 0 Parts 483 Vue 0 Aperçu